Humanized and chimeric N-terminal amyloid beta-antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 15, 2004
Grant Date -
N/A
app pub date -
Nov 28, 2000
filing date -
Dec 2, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A.beta. in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A.beta. and antibodies binding to the same.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully